Studies have demonstrated that transitioning between GLP-1 receptor agonists is generally well-tolerated when conducted appropriately, with patients able to maintain therapeutic benefits throughout the transition process
Proper storage is essential to maintain its potency for the duration of your study
If you are taking warfarin or other coumarin anticoagulants, increased monitoring of your INR (blood clotting test) may be needed when starting or increasing your liraglutide dose
2014, 157 , 323331 Maeng, J
Yes, if tirzepatide remains ineffective after optimization of dose, adherence, and lifestyle factors, switching to alternative GLP-1 receptor agonists like semaglutide or adding complementary diabetes medications may be appropriate